Healthy Extracts Reports Record Second Quarter 2022, Net Revenue up 93% with Strong Subscription-Based Revenue Growth
LAS VEGAS, Aug. 15, 2022 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator…
News
vTv Therapeutics Announces 2022 Second Quarter Financial Results and Provides Corporate Update
Paul Sekhri appointed as President, Chief Executive Officer and Board member. Entered into agreements with…
Deveron Announces Dates for Q2 2022 Earnings Release
Toronto, Ontario–(Newsfile Corp. – August 15, 2022) – Deveron Corp. (TSXV: FARM) (“Deveron” or the…
Plurilock Closes First Tranche of Non-Brokered Private Placement of Convertible Debenture Units
Vancouver, British Columbia–(Newsfile Corp. – August 15, 2022) – Plurilock Security Inc. (TSXV: PLUR) (OTCQB:…
Siebert Reports Second Quarter 2022 Financial Results
NEW YORK–(BUSINESS WIRE)–Siebert Financial Corp. (NASDAQ: SIEB) (“Siebert”), a mission-driven provider of financial services, today…
Resverlogix Announces Appointment of New Chief Scientific Officer
CALGARY, Alberta, Aug. 15, 2022 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) today announced the…
ABVC BioPharma Reports Second Quarter 2022 Financial and Operational Results
FREMONT, CA, Aug. 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (Nasdaq:…
Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2022 and Recent Corporate Progress
SAN DIEGO, Aug. 15, 2022 (GLOBE NEWSWIRE) — Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company”…
ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results
TORONTO, Ontario and CAMBRIDGE, Massachusetts, Aug. 15, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX:…
Avicanna Reports Q2 2022 Financial Statement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer
CAMBRIDGE, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan Oncology”), a…
CinCor Pharma Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
WALTHAM, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a…
TransCode Therapeutics Reports Second Quarter 2022 Results; Provides Business Update
BOSTON, Aug. 15, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology…
Reviva Pharmaceuticals Holdings, Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights
– Enrollment on pace for ongoing pivotal Phase 3 RECOVER trial – – Topline data…
Aileron Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
Company continues to advance ALRN-6924 as a selective chemoprotective agent for all patients with p53-mutated…
Sanara MedTech Inc. Announces Second Quarter 2022 Results
FORT WORTH, TX, Aug. 15, 2022 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” the “Company,”…
Homology Medicines Reports Second Quarter 2022 Financial Results, Recent Highlights and Provides Business Update
– On Track for Updates on pheEDIT and juMPStart Programs by End of 2022 –…
Panbela Provides Business Update and Reports Q2 2022 Financial Results
MINNEAPOLIS, Aug. 15, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
WonderFi Announces Q3 2022 Financial Results
Successfully Integrates Bitbuy Acquisition, Acquires Coinberry and Lists on the Toronto Stock Exchange Vancouver, British…
MediaValet Reports Second Quarter 2022 Results
Net New ARR increases 89% year-on-year resulting in record Q2 Vancouver, British Columbia–(Newsfile Corp. –…